0001084048false00010840482022-06-132022-06-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of
1934
Date of Report (Date of earliest event reported)
June 13, 2022
Ziff Davis, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
0-25965
|
|
47-1053457
|
(State or other jurisdiction of incorporation or
organization)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
114 5th Avenue, 15th Floor
New York, New York 10011
(Address of principal executive offices)
(212) 503-3500
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, $0.01 par value |
ZD |
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
o
Item 5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On June 13, 2022, Ziff Davis, Inc. (formerly known as J2 Global,
Inc.) (the “Company”) entered into employment agreements with each
of (i) Vivek Shah, President and Chief Executive Officer, (ii) Bret
Richter, Chief Financial Officer and (iii) Jeremy D. Rossen,
Executive Vice President, General Counsel and Secretary (each an
“Employment Agreement”).
Employment Agreement with Mr. Vivek Shah
The term of Mr. Shah’s Employment Agreement commenced on June 13,
2022 (the “Effective Date”) and will continue until the earlier of
(i) the three (3) year anniversary of the Effective Date (such
three (3) year period, the “Initial Term”) and (ii) the termination
of Executive’s employment with the Company for any reason.
Following the Initial Term, the period of Executive’s employment
pursuant to the Employment Agreement will be extended automatically
for one (1) year periods (each successive one (1) year period, a
“Renewal Term”) unless either party notifies the other party of
nonrenewal at least three hundred sixty-five (365) days prior to
the end of the Initial Term or the then current Renewal Term, as
applicable (the Initial Term and the Renewal Term collectively
referred to as the “Employment Period”). Mr. Shah’s Employment
Agreement provides for an annual base salary of $1,000,000 and a
current annual target bonus opportunity of 100% of Mr. Shah’s
annual base salary. During the Employment Period, Mr. Shah will be
eligible to participate in any long-term incentive compensation
plans generally made available to senior executives of the Company
and will also be entitled to participate in the Company’s benefit
plans and programs made available to the Company’s employees
generally, as such plans and programs may be in effect from time to
time.
Under Mr. Shah’s Employment Agreement, if Mr. Shah’s employment
with the Company is terminated by the Company other than for
“cause” (as defined in the Employment Agreement), or by Mr. Shah
for “good reason” (as defined in the Employment Agreement) and such
termination is within three (3) months prior to or within two (2)
years following a “change in control” of the Company (as defined in
the Employment Agreement) (a “Qualifying CIC Termination”), then
Mr. Shah shall be entitled to receive (i) a cash severance amount
equal to three (3) times the sum of Mr. Shah’s then current base
salary and target annual bonus, payable in a lump sum, (ii) a pro
rata bonus payment based on actual performance for the year of
termination, (iii) continued medical benefits for eighteen (18)
months and (iv) equity vesting benefits, whereby Mr. Shah’s
outstanding and unvested equity awards as of such termination shall
be treated in accordance with the Company’s j2 Global, Inc. 2015
Stock Option Plan (or any successor plan) (the “Stock Plan”) and
the applicable award agreements thereunder. If such termination is
not a Qualifying CIC Termination, Mr. Shah shall be entitled to
receive (i) a cash severance amount equal to two (2) times the sum
of his then current base salary and target annual bonus, payable in
equal installments over a period of twelve (12) months in
accordance with the Company’s standard payroll procedures, (ii) a
pro rata bonus payment based on actual performance for the year of
termination and (iii) continued medical benefits for eighteen (18)
months. The foregoing severance benefits are subject to Mr. Shah’s
execution and non-revocation of a general release of claims in
favor of the Company.
Mr. Shah’s Employment Agreement contains restrictive covenants by
Mr. Shah, including a perpetual confidentiality covenant and an
employee and customer non-solicitation covenant that applies during
the Employment Period and for the one (1) year period following the
termination of Mr. Shah’s employment for any reason.
Employment Agreements with Messrs. Bret Richter and Jeremy D.
Rossen
The terms of Messrs. Richter’s and Rossen’s Employment Agreements
also commenced on the Effective Date and will continue until the
earlier of (i) the three (3) year anniversary of the Effective Date
and (ii) the termination of Executive’s employment with the Company
for any reason. Following the Initial Term, the period of
Executive’s employment pursuant to the Employment Agreement will be
extended automatically for one (1) year periods unless either party
notifies the other party of nonrenewal at least three hundred
sixty-five (365) days prior to the end of the Initial Term or the
then current Renewal Term, as applicable. Mr. Richter’s Employment
Agreement provides for an annual base salary of $625,000 and an
annual target bonus opportunity of $625,000. Mr. Rossen’s
Employment Agreement provides for an annual base salary of $475,000
and an annual target bonus opportunity of $300,000. During the
Employment Period, each of Messrs. Richter and Rossen will be
eligible to participate in any long-term incentive compensation
plans generally made available to senior executives of the Company
and will also be entitled to participate in the Company’s benefit
plans and programs made available to the Company’s employees
generally, as such plans and programs may be in effect from time to
time.
Under Messrs. Richter’s and Rossen’s Employment Agreements, upon a
Qualifying CIC Termination, Messrs. Richter or Rossen, as
applicable, shall be entitled to receive (i) a cash severance
amount equal to two (2) times the sum of Messrs. Richter’s or
Rossen’s then current base salary and target annual bonus, payable
in a lump sum, (ii) a pro rata bonus payment based on actual
performance for the year of termination, (iii) continued medical
benefits for eighteen (18) months and (iv) equity vesting benefits,
whereby Messrs. Richter’s or Rossen’s outstanding and unvested
equity awards as of such termination shall be treated in accordance
with the Stock Plan and the applicable award agreements thereunder.
If such termination is not a Qualifying CIC Termination, Messrs.
Richter or Rossen, as the case may be, shall be entitled to receive
(i) a cash severance amount equal to one (1) times the sum of his
then current base salary and target annual bonus, payable in equal
installments over a period of twelve (12) months in accordance with
the Company’s standard payroll procedures, (ii) a pro rata bonus
payment based on actual performance for the year of termination,
(iii) continued medical benefits for twelve (12) months and (iv)
equity vesting benefits, whereby Messrs. Richter’s or Rossen’s
outstanding and unvested time-based awards that would
have been vested during the twelve (12) month period following the
executive’s termination date shall vest in full and the executive’s
then outstanding and unvested performance-based equity awards will
remain outstanding and eligible to vest during the twelve (12)
months following the applicable termination date. The foregoing
severance benefits are subject to Messrs. Richter’s or Rossen’s, as
the case may be, execution and non-revocation of a general release
of claims in favor of the Company.
Messrs. Richter’s and Rossen’s Employment Agreements contain
restrictive covenants by Messrs. Richter and Rossen, including a
perpetual confidentiality covenant, an employee and customer
non-solicitation covenant that applies during the Employment Period
and for the one (1) year period following the termination of such
executive’s employment for any reason as well as non-competition
covenants that restrict such executive’s ability to engage in
competitive activities during the Employment Period and for the six
(6) month period following the termination of such executive’s
employment for any reason, except that the non-competition covenant
will not apply if Messrs. Richter or Rossen, as the case may be,
voluntarily resigns without good reason.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
|
|
|
|
|
|
|
|
Exhibit
Number |
|
Description |
10.1 |
|
|
10.2 |
|
|
10.3 |
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL
document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ziff Davis, Inc.
(Registrant)
|
|
|
|
|
Date: |
June 15, 2022 |
By: |
/s/ Jeremy Rossen |
|
|
|
Jeremy Rossen
Executive Vice President, General Counsel and Secretary |
j2 Global (NASDAQ:JCOM)
Historical Stock Chart
From Jul 2022 to Aug 2022
j2 Global (NASDAQ:JCOM)
Historical Stock Chart
From Aug 2021 to Aug 2022